CSL

CSL Financing Cash Flow

-$268.60MTTM · USD

Period ending:

CSL FY Cash from FinancingUSD
CSL FY Cash from Financing1989-12-31: -$11.90M1990-12-31: -$2.40M1991-12-31: -$10.50M1992-12-31: $8.10M1993-12-31: -$22.20M1994-12-31: -$14.60M1995-12-31: -$22.80M1996-12-31: $84.50M1997-12-31: $3.60M1998-12-31: $38.30M1999-12-31: -$43.90M2000-12-31: $145.69M2001-12-31: $1.46M2002-12-31: -$168.65M2003-12-31: -$53.71M2004-12-31: -$18.02M2005-12-31: -$49.18M2006-12-31: $74.45M2007-12-31: -$182.40M2008-12-31: $35.20M2009-12-31: -$274.20M2010-12-31: $223.80M2011-12-31: $256.40M2012-12-31: -$20.60M2013-12-31: -$41.50M2014-12-31: -$20.20M2015-12-31: -$173.00M2016-12-31: -$261.10M2017-12-31: $627.20M2018-12-31: -$540.70M2019-12-31: -$461.20M2020-12-31: -$24.70M2021-12-31: $488.10M2022-12-31: -$862.00M2023-12-31: -$1.35B2024-12-31: -$2.11B2025-12-31: -$503.70M$627.20M-$2.11B
1989-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

CSL financing cash flow history

Cash from issuing/repaying debt and equity. The available annual fiscal periods series contains 37 observations from Dec 31, 1989 to Dec 31, 2025.

Carlisle Companies Incorporated Common Stock Financing Cash Flow — Annual fiscal periods (USD)
Period endingFinancing Cash Flow (USD)
-503,700,000
-2,110,199,999
-1,349,700,000
-862,000,000
488,100,000
-24,700,000
-461,200,000
-540,700,000
627,200,000
-261,100,000
-173,000,000
-20,200,000
-41,500,000
-20,600,000
256,400,000
223,800,000
-274,200,000
35,200,000
-182,396,000
74,450,000
-49,176,000
-18,021,000
-53,708,000
-168,650,000
1,455,000
145,689,000
-43,900,000
38,300,000
3,600,000
84,500,000
-22,800,000
-14,600,000
-22,200,000
8,100,000
-10,500,000
-2,400,000
-11,900,000

Compare financing cash flow

All CSL financial metrics · CSL stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.